Company intelligence / Profile preview
Ainos, Inc.
San Diego, California, United Statesainos.com ↗
- Ownership
- Public · AIMD
- Employees
- ~44
- Development stage
- Commercial
01
Overview
Developing AI-powered point-of-care testing solutions and low-dose interferon therapeutics. Has commercialized products including SARS-CoV-2 Antigen Rapid Test Kit and VELDONA Pet health supplements.
- Therapeutic areas
- HematologyImmunologyRare DiseasesInfectious Diseases
- Modalities
- Low-dose interferon therapeuticsSynthetic RNA
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Advanced Semiconductor Engineering, Inc. (ASE)National Health Research Institutes (Taiwan)
04
Financials
- Market cap
- $4.6M
- Total revenue
- $124.2K
- Enterprise value
- $17M
Beyond the preview
Go deeper on Ainos, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ainos, Inc..